Drug
Interleukin 15 Superagonist
Interleukin 15 Superagonist: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Interleukin-15 Superagonist (N-803) NCT04290546 | Phase 1 | Squamous Cell Carcinoma of the Head and Neck |
Latest
No recent events.
Follow Interleukin 15 Superagonist on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.